Why Moderna Stock Surged Today
Shares of Moderna (NASDAQ: MRNA) jumped 8.3% on Thursday after the biotech said it has dosed the first participants in a study evaluating its new coronavirus booster-vaccine candidates.
Moderna's COVID-19 vaccine is believed to offer some protection against all of the most common coronavirus variants, including the strains first identified in the U.K. and South Africa. Yet the biotech is testing whether a booster dose could provide even more protection, particularly to people who are more vulnerable to severe forms of the disease.
Moderna's stock price rose sharply on Thursday on optimism for its booster vaccines. Image source: Getty Images.
Source Fool.com
